Rankings / Longevity — Supplements
Tretinoin (all-trans retinoic acid)
Longevity · Retinoid — RAR agonist
Tier A
Bottom line
Read Off Label grades Tretinoin (all-trans retinoic acid) as A (8.0/10) based on very strong evidence, very strong benefit magnitude, and a med-risk safety profile.
Topical tretinoin has multiple RCTs reporting changes in photoaging outcomes (Kligman tradition).
Studied, labeled, or reported-use context: 0. — Rx (tretinoin); adapalene 0.1% OTC since 2016; not individualized guidance.
What the evidence says
Topical tretinoin has multiple RCTs reporting changes in photoaging outcomes (Kligman tradition). Adapalene is the closest OTC alternative. Clinical and dermatology protocols commonly apply tretinoin to dry skin because wet skin can increase irritation, and pair retinoid use with photoprotection. Irritation often occurs during the first weeks to months; severity and persistence vary.
Mechanism
Active metabolite of vitamin A; binds retinoic acid receptors (RARα/β/γ); normalizes follicular keratinization, increases collagen synthesis, thickens epidermis, fades dyspigmentation
Studied, labeled, or reported dose & route
0.025-0.1% topical cream/gel nightly on dry skin; tolerability protocols commonly begin at 2-3 applications per week and increase gradually
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
- PubMed · PMID 3286781
- PubMed · PMID 17515510
- pmc.ncbi.nlm.nih.gov
- PubMed · PMID 34292058
- PubMed · PMID 35642229
- PubMed · PMID 28018771
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Tretinoin (all-trans retinoic acid)'s effects?
- Read Off Label rates the evidence for Tretinoin (all-trans retinoic acid) as Very Strong and the benefit magnitude as very strong, producing an overall grade of A (8.0/10). Topical tretinoin has multiple RCTs reporting changes in photoaging outcomes (Kligman tradition).
- What safety findings are reported for Tretinoin (all-trans retinoic acid)?
- Tretinoin (all-trans retinoic acid) has a med risk profile in the database. Med (irritation, dryness, purging, photosensitivity, pregnancy safety concern; pregnancy guidance generally advises discontinuation) Legal status: Rx (tretinoin); adapalene 0.1% OTC since 2016.
- What doses or routes are reported for Tretinoin (all-trans retinoic acid)?
- 0.025-0.1% topical cream/gel nightly on dry skin; tolerability protocols commonly begin at 2-3 applications per week and increase gradually This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Tretinoin (all-trans retinoic acid) work?
- Active metabolite of vitamin A; binds retinoic acid receptors (RARα/β/γ); normalizes follicular keratinization, increases collagen synthesis, thickens epidermis, fades dyspigmentation
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.